Clinical Trial Update: Is Our Microbiome a Predictor of Cardiac Risk

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial related to the gut microbiome and cardiac risk is currently enrolling by invitation for patients with coronary artery dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Coronary Artery Disease | Status: ENROLLING_BY_INVITATION